HDACi has been revealed to reverse heterochromatin-mediated FXN silencing by increasing mRNA expression and protein level of frataxin and promoting histone hyperacetylation in lymphocytes derived from patients with FRDA [168,169,170]. Here, FXN is linked to Friedreich ataxia.